Need help? +44 (0) 7457 418426

MEDICINE DETAILS

Ammonaps

Active ingredient: Sodium Phenylbutyrate

Neutral reference profile for an independent medicine-access consultancy enquiry about Ammonaps (Sodium Phenylbutyrate). No medicine is offered for sale.

NEXT STEP

Choose the strength and pack

✓ If you are unsure, choose “I do not know”.

These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.

ABOUT THIS MEDICINE

What is Ammonaps used for?

Ammonaps (sodium phenylbutyrate) is an adjunctive therapy indicated for the chronic management of urea cycle disorders that involve deficiencies of the enzymes carbamylphosphate synthetase, ornithine transcarbamylase, or argininosuccinate synthetase.

It is indicated for:

  • 'Early-onset' disease in babies who show a complete lack of one or more of these enzymes within the first 28 days after birth.
  • 'Late-onset' disease in patients who show a partial lack of an enzyme after the age of one month and have had brain damage caused by high blood ammonia levels.

It is available in tablet form, each containing 500 mg of sodium phenylbutyrate.

This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.

RECORDED PRODUCT PROFILE

Ammonaps identity, dosage form and pack information.

The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.

Brand recordAmmonaps
Active ingredientSodium Phenylbutyrate
Dosage formtablets, granules
Recorded options2
Directory areaMetabolic & Genetic Disorders
Catalogue synchronised

Recorded strength and pack options

Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.

  1. 500 mg · 250 tablets Catalogue organisation: Immedica Pharma AB
  2. 940 mg/g granules · 266 g Catalogue organisation: Immedica Pharma AB

OFFICIAL SOURCES

Check the Ammonaps record at an official source.

Search for “Ammonaps” or “Sodium Phenylbutyrate”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.

SERVICE BOUNDARY

Information checking and independent enquiry support for Ammonaps.

OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.

Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.

CLEAR ANSWERS

Frequently asked questions about Ammonaps

01What is Ammonaps?

This directory record associates the brand name Ammonaps with the active ingredient Sodium Phenylbutyrate. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.

02Which Ammonaps strengths and packs are recorded?

The catalogue currently shows: 500 mg · 250 tablets; 940 mg/g granules · 266 g. Check the complete strength, dosage form and pack description against the prescription and medicine box.

03Who manufactures Ammonaps?

Catalogue records currently name: Immedica Pharma AB. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.

04Do the listed options confirm stock or access?

No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.

05What affects a possible estimated medicine cost for Ammonaps?

A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Ammonaps, payment request, stock guarantee or binding offer.

06Can I buy Ammonaps from this website?

No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.